Mother-to-child transmission (MTCT) of HIV remains a significant public health challenge in
Uganda, necessitating a focused examination of the state of laboratory systems to ensure …

In sub-Saharan Africa (SSA) the burden of non-nucleoside reverse transcriptase inhibitor
(NNRTI) HIV drug resistance (HIVDR) has been high over the years. Therefore, in 2018 the …

Background The persistent efforts of HIV/AIDS epidemiology remain one of the world's most
important community health threats. To avoid becoming an epidemic, UNAIDS has set three …

Background: Galectin-9 induces HIV reactivation and also contributes to non-AIDS events
through inflammaging. Hence, it is important to assess its levels in HIV-infected individuals …

Background While national adoption of universal HIV treatment guidelines has led to
improved, timely uptake of antiretroviral therapy (ART), longer-term care outcomes are …

Introduction: In 2021, the number of people affected by displacement worldwide reached the
highest on record, with an estimated 30.5 million refugees and 4.6 million asylum seekers …

Background: Data are required regarding the feasibility of conducting a randomized trial of
point-of-care viral load (VL) testing to guide management of HIV viremia and to provide …

Introduction Antiretroviral therapy (ART) monitoring using viral load (VL) testing is
challenging in high‐burden, limited‐resources settings. Chemokine IP‐10 (interferon …

Background HIV drug resistance (DR) is a growing threat to the durability of current and
future HIV treatment success. DR testing (DRT) technologies are very expensive and …

South Africa rolled out dolutegravir (DTG) as first-line antiretroviral therapy (ART) in
December 2019 to overcome high rates of pretreatment non-nucleoside reverse …